Read the News and Earn Credit - Click for Credit

For news and views that matter to gastroenterologist
Click here »

Highlights of Skin Disease Education Foundation 38th Annual Hawaii Dermatology Seminar


Bookmark and Share
06/15/14

CME-Certified Supplements: 3.0 CME Credits

Skin & Allergy
News

Seminars in Cutaneous
Medicine & Surgery

 

CME-Certified Videos:  3.0 CME Credits

Videos from the Skin Disease Education Foundation
38th Annual Hawaii Dermatology Conference


Partial Credit Available, Claim Credit Commensurate with Participation in this Activity!

Supported by educational grants from
• AbbVie, Inc.
• Eli Lilly and Company
• Genentech, Inc.
• Merz, Inc.
• Novartis Pharmaceuticals Corporation

In affiliation with:

Jointly provided by:

 

 

Activity Information

Original Release Date: June 2014
Most Recent Review Date: June 2014
Expiration Date: July 31, 2016
Estimated Time to Complete Activity: 3.0 hours
Medium or Combination of Media Used: Written Supplement
Method of Physician Participation: Journal Supplement
Hardware/Software Requirements: High-speed Internet connection

 

 

Target Audience

This educational activity is designed for dermatologists, primary care physicians, nurses, and other health care professionals involved in meeting the skin-care needs of patients.

 

Educational Needs

Building on advances in molecular biology and clinical science, dermatology has evolved into a diverse specialty that encompasses elements of oncology, rheumatology, immunology, plastic and aesthetic surgery, and primary care. Clinical practitioners are continually challenged to remain abreast of scientific developments and emerging standards of care.

Based on the knowledge and expertise of leading clinical scientists, the following educational activity offers a concise yet thorough review of recent advances and evolving concepts in the field of dermatology. The discussions cover a variety of topics to address the informational needs of clinicians whose practices and interests reflect the diversity of their specialty

 

Learning Objectives

After reading and studying this enduring journal supplement, participants should be able to:

  • Describe current approaches to treatment of psoriasis.
  • Identify systemic therapies used to treat psoriasis, including biological and nonbiological agents.
  • Recognize the need for ongoing evaluation of drug safety.
  • Describe recent developments in the management of basal cell carcinoma.
  • Utilize techniques involving the application of hyaluronic acid-based fillers and neurotoxins for facial rejuvenation.

 

 

Accreditation

Joint Providership

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville School of Medicine and Global Academy for Medical Education LLC. The University of Louisville School of Medicine is accredited by the ACCME to provide continuing education for physicians.

Designation Statement

The University of Louisville School of Medicine designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

 

 

Activity Information

Original Release Date: June 2014
Most Recent Review Date: June 2014
Expiration Date: June 30, 2016
Estimated Time to Complete Activity: 3.0 hours
Medium or Combination of Media Used: Videos
Method of Physician Participation: Webcast Videos
Hardware/Software Requirements: High-speed Internet connection

 

 

Target Audience

This educational activity is designed for dermatologists, primary care physicians, nurses, and other health care professionals involved in meeting the skin-care needs of patients.

 

Educational Needs

Building on advances in molecular biology and clinical science, dermatology has evolved into a diverse specialty that encompasses elements of oncology, rheumatology, immunology, plastic and aesthetic surgery, and primary care. Clinical practitioners are continually challenged to remain abreast of scientific developments and emerging standards of care.

Based on the knowledge and expertise of leading clinical scientists, the following educational activity offers a concise yet thorough review of recent advances and evolving concepts in the field of dermatology. The discussions cover a variety of topics to address the informational needs of clinicians whose practices and interests reflect the diversity of their specialty.

 

Learning Objectives

After reading and studying this enduring video, participants should be able to:

  • Describe current approaches to treatment of psoriasis.
  • Identify systemic therapies used to treat psoriasis, including biological and nonbiological agents.
  • Recognize the need for ongoing evaluation of drug safety.
  • Describe recent developments in the management of basal cell carcinoma.
  • Utilize techniques involving the application of hyaluronic acid-based fillers and neurotoxins for facial rejuvenation.

 

 

Accreditation

Joint Providership

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville School of Medicine and Global Academy for Medical Education LLC. The University of Louisville School of Medicine is accredited by the ACCME to provide continuing education for physicians.

Designation Statement

The University of Louisville School of Medicine designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

 

Faculty

Craig L. Leonardi, MD, Chair
Clinical Professor of Dermatology
Saint Louis University
Central Dermatology
St Louis, Missouri

Sue Ellen Cox, MD
Clinical Associate Professor
University of North Carolina at Chapel Hill
Raleigh-Durham, North Carolina

Joseph F. Fowler, Jr, MD
Medical Director
Skin Disease Education Foundation
Clinical Professor of Dermatology
University of Louisville, KY

Michael S. Kaminer, MD
Assistant Clinical Professor of Dermatology
Section of Dermatologic Surgery and Oncology,
Yale Medical School
Adjunct Assistant Professor of Medicine (Dermatology)
Dartmouth Medical School
Adjunct Assistant Professor, Dermatology
Brown University School of Medicine
Chestnut Hill, Massachusetts

Brian F. Mandell, MD, PhD
Professor and Chairman of Medicine
Department of Rheumatic and Immunologic Diseases
The Cleveland Clinic
Cleveland, Ohio

Mark G. Rubin, MD
Associate Professor of Dermatology
University of California, San Diego
Private Practice
Beverly Hills, California

Roberta Senglemann, MD, FAAD
Clinical Associate Professor
University of California, Irvine
Private Practice
Santa Barbara, CA

James E. Sligh, Jr, MD, PhD
Division Chief, Dermatology
The University of Arizona
College of Medicine
Tucson, Arizona

Jeffrey M. Sobell, MD
Assistant Professor of Dermatology
Tufts School of Medicine
Director, Psoriasis Treatment Center
Skincare Physicians
Chestnut Hill, Massachusetts

Nowell Solish, MD, FRCP(C)
Assistant Professor
University of Toronto
Toronto, Ontario, Canada

Christopher B. Zachary, MD, FRCP

Christopher B. Zachary, MD, FRCP
Skin Disease Education Foundation
Medical Director
Professor and Chair
Department of Dermatology
University of California
Irvine, CA

>> Back to Top

Disclosures

As a sponsor accredited by the ACCME, the University of Louisville School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty participating in this CME activity were asked to disclose the following:

  1. Names of proprietary entities producing health care goods or services— with the exemption of nonprofit or government organizations and non– health-related companies—with which they or their spouse/partner have, or have had, a relevant financial relationship within the past 12 months. For this purpose, we consider the relevant financial relationships of a spouse/partner of which they are aware to be their financial relationships.
  2. Describe what they or their spouse/partner received (eg, salary, honorarium).
  3. Describe their role.
  4. No relevant financial relationships.

CME & PD Advisory Board Members have no relevant financial relationships with any commercial interests: Soon Bahrami, MD; W. Daniel Cogan, EdD, FAODME; Douglas Coldwell, MD, PhD; Justin L. Costa, MD; James Creg; Daniel Da Justa, MD; Adair Heyl, PhD; Christopher Jones, MD; Lucy Juett, MS; Gerald Larson, MD; Rana Latif, MD; Kimberly Moore; Karen Napolilli; Lisa J. Pfitzer, MD; Scott Plantz, MD; Kerri Remmel, MD, PhD; Michael D. Stillman, MD; Uldis Streips, PhD; Kathy M. Vincent, MD; Lori Wagner, MD; Angela Wetherton, MD; and Stephen Wheeler, MD.

CME Reviewer: Cindy England Owen, MD, Assistant Professor, Associate Program Director, Division of Dermatology, University of Louisville School of Medicine, has no relevant financial relationships with any commercial interests.

Sue Ellen Cox, MD, has been a consultant and/or investigator and/or speaker for Allergan Inc., Medicis, a division of Valeant Pharmaceuticals International, Inc., and Merz, Inc.

Michael S. Kaminer, MD, has been a consultant and/or investigator and/ or speaker for Allergan, Cabochon Aesthetics Inc., Cytrellis Biosystems, Inc., Merz, Miramar Labs, Inc., Myoscience, Inc., and ZELTIQ Aesthetics, Inc.

Craig L. Leonardi, MD, has been a consultant and/or investigator and/or speaker and/or advisory board member for AbbVie, Inc., Amgen Inc., Anacor Pharmaceuticals, Inc., Celgene Corporation, Janssen Biotech, Inc., Eli Lilly and Company, Galderma Laboratories, L.P., GlaxoSmithKline, Incyte Corporation, LEO Pharma Inc., Maruho Co., Ltd., Novartis Pharmaceuticals Corporation, Novo Nordisk, Inc., Pfizer Inc., Schering-Plough Corporation, Sirtis Pharmaceuticals, Inc., Stiefel Laboratories, Inc.,TOLMAR Pharmaceuticals, Inc., Vascular Biogenics Ltd., and Warner Chilcott plc.

Brian F. Mandell, MD, PhD, has no relevant financial relationships with any commercial interests.

Mark G. Rubin, MD, has been a consultant for Allergan and Merz.

James E. Sligh, Jr, MD, PhD, has been a speaker and/or advisory board member for Genentech, Inc.

Roberta Sengelmann, MD, FAAD has been a consultant and/or advisory board member and/or researcher for Allergan, Inc., Merz Pharmaceuticals, LLC, Theraplex, Genentech, Kythera and Medicis, a division of Valeant Pharmaceuticals.

Joseph F. Fowler, Jr, MD has been a consultant and/or speaker and/or investigator For 3M, AbbVie, Inc. Allerderm Laboratories, Allergan Inc., Amgen Inc., Janssen Biotech, Inc, Dow Pharmaceutical Sciences, Inc., Eli Lilly and Company, Galderma Laboratories, L.P., GlaxoSmithKline, Johnson & Johnson Consumer Products Company, Medicis, a division of Valeant Pharmaceuticals, Merck & Co. Inc., Merz Inc., Novartis Pharmaceuticals Corporation, Promius Pharma, Pfizer Inc., Quinnova Pharmaceuticals, Ranbaxy Laboratories, SmartPractice, Taisho Pharmaceutical Co., Ltd., Taro Pharmaceutical Industries Ltd andValeant Pharmaceuticals International.

Jeffrey M. Sobell, MD, has been a consultant and/or speaker and/or investigator for AbbVie, Amgen, Celgene, Eli Lilly, Janssen Biotech, and Merck.

Nowell Solish, MD, FRCP(C), has been a consultant and/or speaker and/or investigator for Allergan and Medicis, a division of Valeant Pharmaceuticals.

Charles Bankhead has no relevant financial relationships with any commercial interests.

Sylvia H. Reitman, MBA, has no relevant financial relationships with any commercial interests.

Shirley V. Jones, MBA, has no relevant financial relationships with any commercial interests.

University of Louisville CME & PD Privacy Policy

All information provided by course participants is confidential and will not be shared with any other parties for any reason without permission.

>> Back to Top


click me